Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7529

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

Chemical structure diagram of atorvastatin calcium showing its molecular components with notation for calcium ions and water molecules as part of the compound's hydrated form.*

FDA Label Image

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)

A line graph depicting cumulative incidence (%) over a period of 3.5 years for Atorvastatin versus placebo. The solid line represents Atorvastatin and the dashed line represents placebo, showing lower cumulative incidence for Atorvastatin throughout the time frame. The graph includes a hazard ratio (HR) of 0.64 with confidence intervals and a p-value of 0.0005.*

FDA Label Image

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)

A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups. The x-axis represents time in years up to 5 years of follow-up, and the y-axis shows cumulative hazard percentage up to 15%. Solid line represents Atorvastatin, and dashed line denotes placebo. The graph includes a hazard ratio of 0.63 (0.48-0.83) with a p-value of 0.001, indicating statistical data on treatment effect differences over time.*

FDA Label Image

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)

A line graph showing the percentage of subjects experiencing a major cardiovascular event over time, comparing Atorvastatin 10 mg and 80 mg doses over 5 years. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR 0.78) and p-value (0.0002).*

FDA Label Image

Label Image (Lbl500907529)

The label for ATORVASTATIN CALCIUM 20 mg film-coated tablets from A-S Medication Solutions. The label includes the NDC 50090-7529-0 and states that each film-coated tablet contains 21.049 mg atorvastatin calcium equivalent to 20 mg atorvastatin. The packaging contains 90 tablets and storage instructions specify 68 to 77 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.